Potential drug targets for ALS revealed in study using CRISPR
In a new application of gene-editing technology, researchers at the Stanford University School of Medicine have gleaned insights into the genetic underpinnings of amyotrophic lateral sclerosis, a neurodegenerative disease ...
Mar 5, 2018
0
170